Home › Stocks › NMRA

Neumora Therapeutics, Inc. (NMRA): insider buying, hedge funds & Congress trades

Neumora Therapeutics, Inc. (NMRA): 3 insider purchases in the last two years.

Insider buying

FiledInsiderSharesPriceValueType
Oct 29, 2025ARCH Venture Partners VIII, LLC
TenPercentOwner
1,915,700$2.61$5.0Mno history
Oct 29, 2025ARCH Venture Partners XII, LLC
TenPercentOwner
1,915,700$2.61$5.0Mno history
Oct 29, 2025Burow Kristina
Director, TenPercentOwner
1,915,700$2.61$5.0Mno history

Open-market purchases from SEC Form 4. "Opportunistic" = this insider trades every year but not on a fixed schedule (Cohen, Malloy & Pomorski); "routine" buys carry little information.

Get alerts for NMRA

Free account. Know when insiders, famous funds or Congress trade it.

Start free